
Predictive AI is a startup founded by twin professors from Johns Hopkins University, specializing in liquid biopsy and pharmacogenomics to advance 5P medicine (Personalized, Predictive, Preventive, Participatory, Precision). Their core technology offers early disease detection through a simple blood test, providing non-invasive, low-cost, and rapid results with higher sensitivity and specificity compared to traditional methods. They also leverage pharmacogenomics to predict individual drug responses based on genetic characteristics, enabling personalized prescription. The company aims to increase people's health span through personalized and preventive medicine, with a focus on developing digital twin solutions for disease prediction and customized healthcare.

Predictive AI is a startup founded by twin professors from Johns Hopkins University, specializing in liquid biopsy and pharmacogenomics to advance 5P medicine (Personalized, Predictive, Preventive, Participatory, Precision). Their core technology offers early disease detection through a simple blood test, providing non-invasive, low-cost, and rapid results with higher sensitivity and specificity compared to traditional methods. They also leverage pharmacogenomics to predict individual drug responses based on genetic characteristics, enabling personalized prescription. The company aims to increase people's health span through personalized and preventive medicine, with a focus on developing digital twin solutions for disease prediction and customized healthcare.